Atrial Fibrillation |
KCNIP1
|
High atrial rate |
[80] |
Long QT Syndrome |
KCNH2
|
Severe repolarization |
[81] |
Atrial Fibrillation |
PRRX1
|
Atrial action potential duration |
[82] |
Dilated Cardiomyopathy |
HSPB7
|
Cardiac fibrosis, cardiomegaly and sarcomeric abnormalities |
[83] |
Congenital Heart Defects |
PBX3
|
Myocardial morphogenesis defects |
[84] |
Mitral Valve Prolapse |
LMCD1, TNS1
|
Increased atrioventricular regurgitation, moderate reduction in cardiac looping |
[86] |
Atrioventricular Septal Defect |
NFATC1
|
Cardiac looping defects and altered atrioventricular canal patterning |
[87] |
Heart Rate Variability |
GNG11, SYT10, RGS6, HCN4, NEO1, KIAA1755
|
Sinoatrial pauses and arrests, cardiac edema and uncontrolled atrial contractions |
[88] |
Lipid Associated-Cardiomyopathy |
APOOP1
|
Increased the LDL-C levels, increase in the average number of vascular plaques |
[95] |
Lipid Associated-Cardiomyopathy |
PLXND1
|
Modulate angiogenesis, reduced capacity to store lipid in visceral adipose tissue |
[96] |
Congenital Cardiomyopathy |
KIF20A
|
Relative tachycardia, red blood cells proximal to the atrium and cardiac edema |
[97] |